BlueClinical - an Astrum company

BlueClinical is now a founding member of the new pan-European CRO: Astrum, the result of a merger with three other European Companies with complementary skills (Bioclever, from Spain; Popsicube, from France; and Pharmalog, from Germany), and with investment from Henko Partners. BlueClinical remain committed to making each client’s goals our mission, as we provide all the critical conditions necessary for the success of your clinical research project. We provide highly-customized and fully-compliant services, to maximize client’s competitiveness and time-to-market. BlueClinical operates in three different areas: • BlueClinical Phase I: - Conducts phase I studies in healthy subjects and early proof-of-concept studies in selected patient populations, in strict compliance with the highest ethics and regulatory standards. • BlueClinical R&D: - BlueClinical R&D's mission is to fuel translation research by supporting Portuguese institutions and businesses, especially start-ups, in the development of their R&D projects with a view to the subsequent marketing. • BlueClinical Clinical Research Partnership: - BlueClinical CRP is a network of hospitals and primary care centers that serve approximately half (5 million people) of the Portuguese population. The full network operates under a common quality management system to deliver excellence in clinical research. BlueClinical CRP support operationally the clinical research activity in partner health institutions, promoting its development, efficiency and excellence. CRP is your right partner for your clinical trials or observational studies!